The current pages form the SNOMED CT Content Development Canadian Editorial Guidelines for Immunization. They have been reviewed against the latest version of the SNOMED International Editorial Guidelines to ensure alignment between the guidelines, where applicable.
SNOMED International editorial guidelines have been followed and extended to meet specific Canadian requirements as described in these Editorial guidelines.
The Immunization Editorial guidelines provide the explicit format for the different Vaccine component and Subsets.
Each section provides information on the rules for creation of generic and specific vaccine products as well as their active ingredients using SNOMED CT International and the Canadian Edition.
Canada Health Infoway (Infoway) publishes English Generic Editorial Guidelines. These guidelines should be consulted, along with the guidelines in the following pages prior to creating any new content for submission to Infoway.
Implementers should be familiar with the SNOMED International Guidelines prior to creating submissions for new content.
The development of the Immunization content is based on different documents such as:
Main Reference Documentation
Other references, available in French and English, were used as part of this work. It is expected that any future development will consider these:
A) Canadian Products
1- Product monograph
a) For the current vaccine tradename
b) For discontinued vaccine tradename
c) For the current passive immunizing agent tradename
d) For discontinued passive immunizing agent tradename
2- Vaccines and Passive Agents Abbreviations List
a) For the current vaccine
The vaccine abbreviation is created by the Vaccine Vigilance Working Group (VVWG).
b) For the current passive immunizing agent
c) Discontinued vaccine
d) Discontinued passive immunizing agent
3- Marketing Authorization Holder (MAH) vs Manufacturer's abbreviation list
NOTE: Most of the Vaccine tradename and passive immunizing agent tradename product concepts have been developed using the Manufacturer's name and abbreviation. In the April 2019 release, some concepts have been updated to display the MAH instead of the Manufacturer. For details, refer to the Informs tickets BSCT-8425.
In some reference documentation, the Marketing Authorization Holder (MAH) is referred to as the manufacturer. This may not be true in all cases.
a) For the current vaccine tradename
b) For the current passive immunizing agent tradename
B) Non-Canadian Products
This logo is used throughout the guide to identify areas that will require future clarification from the community of practice.
Thank you to the Ontario representatives for their participation in the initial subsets development.
Thank you to the Public Health Agency of Canada (PHAC), Ontario and Manitoba for the French Preferred Terms submissions and review.